Vimarsana
Biggest News Aggregation in the World

Page 42 - Geisel School News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Geisel School. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Geisel School Today - Breaking & Trending Today

Valley News - Jim Kenyon: Dartmouth Health budget cuts come from afar after executives' pricey office move - Vimarsana News

Valley News - Jim Kenyon: Dartmouth Health budget cuts come from afar after executives' pricey office move

In an “internal” message sent out to thousands of employees last month, Dartmouth Health declared belt-tightening measures were a must as it tries to close a $120 million budget gap by the end of September.In other words, most workers shouldn’t expect...

Source: vnews.com
CDC Acknowleges Overcounting COVID-19 Hospitalizations but Suggests It Doesn't Overcount Deaths - Vimarsana News

CDC Acknowleges Overcounting COVID-19 Hospitalizations but Suggests It Doesn't Overcount Deaths

The U.S. government overcounts COVID-19 hospitalizations, officials with the Centers for Disease Control and Prevention (CDC) say, but ...

Corrections: Jan. 28, 2023 - Vimarsana News

Corrections: Jan. 28, 2023

Corrections that appeared in print on Saturday, Jan. 28, 2023.

FDA Panel Backs Shift Toward One-Dose COVID Shot - Vimarsana News

FDA Panel Backs Shift Toward One-Dose COVID Shot

The FDA's vaccine advisers lent support to the agency's plan to try to simplify future COVID shots, with an aim of having many people get just one dose in the fall.

Pulmatrix to Host Key Opinion Leader Webinar "PUR3100 for the Treatment of Acute Migraine: Unlocking the Potential of DHE Treatment" - Vimarsana News

Pulmatrix to Host Key Opinion Leader Webinar "PUR3100 for the Treatment of Acute Migraine: Unlocking the Potential of DHE Treatment"

/PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious disease...